Anti-CD22 (90)Y-epratuzumab tetraxetan combined with anti-CD20 veltuzumab: a phase I study in patients with relapsed/refractory, aggressive non-Hodgkin lymphoma

Por Witzig, Thomas E., Tomblyn, Michael B., Misleh, Jamal G., Kio, Ebenezer A., Sharkey, Robert M., Wegener, William A., Goldenberg, David M.
Publicado no Haematologica (2014)

Overexpression of nucleolin in chronic lymphocytic leukemia cells induces stabilization of bcl2 mRNA

Por Otake, Yoko, Soundararajan, Sridharan, Sengupta, Tapas K., Kio, Ebenezer A., Smith, James C., Pineda-Roman, Mauricio, Stuart, Robert K., Spicer, Eleanor K., Fernandes, Daniel J.
Publicado em 2007